Skip to main content Skip to main navigation menu Skip to site footer

Efektivitas multi drug therapy pada transmisi morbus hansen transplasental

  • Dhelya Widasmara ,
  • Santosa Basuki ,
  • Dea Florensia ,
  • Ade Setyagraha ,
  • Nugrahanti Prasetyorini ,


Introduction: The evidence of transplancental transmission of Morbus Hansen (MH) in animal models is a challenge for MH treatment in pregnancy because it brings anxiety for patients and their fetuses. 

Case: A 31-year-old pregnant woman, first trimester, came with complaints of reddish numbness rash on her hands since 2 years ago. Dermatological examination showed erythematous plaque, multiple, well-defined, irregular borders with hypoaesthesia. There were right and left ulnar nerve enlargement. Acid Fast Bacteria (AFB) from ear lobes and lesion revealed Bacterial Index +2 and Morphological Index 10%. Histopathological examination showed gren zone which indicate MH type BL. Patient was diagnosed with MH Multi Basiler (MB) on G3P2002Ab000 and given MDT MHMB. Postpartum IgM and IgG anti-PGL-1 examination of cord blood and infant blood, also PCR examination of cord blood and amnion showed negative results. Histopathological examination found no AFB on the umbilical cord and placenta. 

Conclusion: MDT is effective in preventing transplacental transmission of MH from mother to fetus.


  1. Direktorat Jenderal Pengendalian Penyakit dan Penyehat Lingkungan. Buku Pedoman Nasional Pengendalian Penyakit MH. Jakarta: Departemen Kesehatan RI. 2012.
  2. World Health Organization. Universal Eliminationof Leprosy Plan Periode: 2016-2020. 2015. p.1-10.
  3. World Health Organization. Global Leprosy: update on the 2012 situation. Weekly epidemiological Record. 2013. p 365-80.
  4. Infodatin MH. Pusat Data dan Informasi Kementrian Kesehatan Republik Indonesia. 2015. p. 1-8.
  5. Bhatia R, et al. Leprosy in Pregnancy: Obstetric Diligence is the Key. Journal of Clinical & Diagnostic Research. 2017;20(1):10-11.
  6. Adiguna MS. Relaps Morbus Hansen (MH) Tipe Borderline-Lepromatosa (BL) pada seorang perempuan hamil. E-Journal Medika. 2018;8(1):1-7.
  7. Nogueira, Paula Sacha Frota, et al. Consequences of the interaction between leprosy and pregnancy. Journal of Nursing UFPE. 2012;3(1):2243-2249.
  8. Brasileira S, Tropical DM, Sacha P, Nogueira F, Rejane E, Moura F, et al. Characteristics of pregnant and lactating women with leprosy. Rev Soc Bras Med Trop. 2015;20(1):48-55.
  9. Anitha B, Malavika S, Kumar B, Ramesh Y. Journal of Drug Delivery and Therapeutics Current trends in drugs avoided in pregnancy. 2018. p342–50.
  10. Khanna N. Leprosy in Pregnancy. In: Kumar H, Kumar B. IAL Textboook of Leprosy (Indian Association of Leprologists). 2nd edition. New Delhi: Jaypee Brothers Medical Publisher. 2015. p. 352-258
  11. Chen Z, Kuang Y, Jiang H, Zhang W, Shi Y, Chokkakula S, Wang H. Intact Mycobacterium leprae Isolated from Placenta of a Pregnant Woman, China. Emerg Infect Dis. 2019;25(8):1604-1607.

How to Cite

Widasmara, D., Basuki, S., Florensia, D., Setyagraha, A., & Prasetyorini, N. (2020). Efektivitas multi drug therapy pada transmisi morbus hansen transplasental. Intisari Sains Medis, 11(2), 425–428.




Search Panel